{"id":"https://openalex.org/W2396735919","doi":null,"title":"[A study on transfer of ceftizoxime into prostatic and vesical tissues].","display_name":"[A study on transfer of ceftizoxime into prostatic and vesical tissues].","publication_year":1984,"publication_date":"1984-02-01","ids":{"openalex":"https://openalex.org/W2396735919","mag":"2396735919","pmid":"https://pubmed.ncbi.nlm.nih.gov/6204521"},"language":"ja","primary_location":{"id":"pmid:6204521","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/6204521","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hinyokika kiyo. Acta urologica Japonica","raw_type":"English Abstract"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113443745","display_name":"T Katsumi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T Katsumi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5109312935","display_name":"K Murayama","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K Murayama","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.19040874,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"30","issue":"2","first_page":"259","last_page":"64"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.9423999786376953,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.9423999786376953,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10279","display_name":"Urinary Bladder and Prostate Research","score":0.045499999076128006,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11232","display_name":"Urinary Tract Infections Management","score":0.008500000461935997,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ceftizoxime","display_name":"ceftizoxime","score":1.0},{"id":"https://openalex.org/keywords/prostatic-hyperplasia","display_name":"prostatic hyperplasia","score":0.8809999823570251},{"id":"https://openalex.org/keywords/intravenous-administration","display_name":"intravenous administration","score":0.5490000247955322},{"id":"https://openalex.org/keywords/prostatitis","display_name":"prostatitis","score":0.7390000224113464},{"id":"https://openalex.org/keywords/escherichia-coli","display_name":"Escherichia coli","score":0.7120000123977661},{"id":"https://openalex.org/keywords/proteus","display_name":"Proteus","score":0.9700000286102295},{"id":"https://openalex.org/keywords/klebsiella","display_name":"Klebsiella","score":0.9890000224113464}],"concepts":[{"id":"https://openalex.org/C2777562237","wikidata":"https://www.wikidata.org/wiki/Q835051","display_name":"Hyperplasia","level":2,"score":0.7148700952529907},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6284220814704895},{"id":"https://openalex.org/C2776869330","wikidata":"https://www.wikidata.org/wiki/Q1082945","display_name":"Ceftizoxime","level":4,"score":0.596879780292511},{"id":"https://openalex.org/C2776235491","wikidata":"https://www.wikidata.org/wiki/Q9625","display_name":"Prostate","level":3,"score":0.5578519105911255},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.5491105914115906},{"id":"https://openalex.org/C2911124710","wikidata":"https://www.wikidata.org/wiki/Q9625","display_name":"Prostatic Diseases","level":4,"score":0.48522305488586426},{"id":"https://openalex.org/C2779464495","wikidata":"https://www.wikidata.org/wiki/Q132229","display_name":"Proteus","level":4,"score":0.42873668670654297},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.312219500541687},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.22827914357185364},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.1565205454826355},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.10890427231788635},{"id":"https://openalex.org/C64778159","wikidata":"https://www.wikidata.org/wiki/Q271021","display_name":"Cephalosporin","level":3,"score":0.08293008804321289},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.07321491837501526},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.069599449634552},{"id":"https://openalex.org/C547475151","wikidata":"https://www.wikidata.org/wiki/Q25419","display_name":"Escherichia coli","level":3,"score":0.06808033585548401},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001692","descriptor_name":"Biological Transport","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001743","descriptor_name":"Urinary Bladder","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D002439","descriptor_name":"Cefotaxime","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002439","descriptor_name":"Cefotaxime","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D002439","descriptor_name":"Cefotaxime","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007275","descriptor_name":"Injections, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011467","descriptor_name":"Prostate","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D011470","descriptor_name":"Prostatic Hyperplasia","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015296","descriptor_name":"Ceftizoxime","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"pmid:6204521","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/6204521","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hinyokika kiyo. Acta urologica Japonica","raw_type":"English Abstract"},{"id":"mag:2396735919","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/6204521","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null},{"id":"mag:2527876638","doi":null,"is_oa":false,"landing_page_url":"http://ci.nii.ac.jp/naid/120002158656","pdf_url":null,"source":{"id":"https://openalex.org/S4306553658","display_name":"\u6ccc\u5c3f\u5668\u79d1\u7d00\u8981","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"\u6ccc\u5c3f\u5668\u79d1\u7d00\u8981","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7145090468","https://openalex.org/W2415446733","https://openalex.org/W7146315286","https://openalex.org/W2410171531","https://openalex.org/W7208561891","https://openalex.org/W2183116125","https://openalex.org/W7208481433","https://openalex.org/W7208331416","https://openalex.org/W7146545020","https://openalex.org/W2020143721"],"abstract_inverted_index":{"Prostatic":[0,41,97],"and":[1,60,124,133],"vesical":[2,61],"tissue":[3,42,62,85,98,123],"levels":[4,43,63],"of":[5,20,23,38,47,67,95,108,144],"Ceftizoxime":[6],"(CZX)":[7],"were":[8,103],"determined":[9],"in":[10,83,100,141],"21":[11],"patients":[12],"with":[13,91],"prostatic":[14,28,84,122,145],"hyperplasia":[15,110],"after":[16,58,86],"the":[17,92,121,142],"intravenous":[18],"administration":[19,59,87],"1":[21],"g":[22],"CZX.":[24],"Serum":[25],"concentration":[26],"on":[27],"surgery":[29],"continued":[30],"to":[31,137],"be":[32,138],"1.3":[33],"fold":[34],"higher":[35,105],"than":[36,106,113],"that":[37],"healthy":[39],"adults.":[40],"attained":[44,64],"a":[45,65],"peak":[46,66],"40.7":[48],"+/-":[49,53,69,80],"1.6":[50],"micrograms/g":[51,71,82],"(mean":[52],"SE)":[54],"at":[55,72],"30":[56,73],"minutes":[57,90],"72.4":[68],"24.8":[70],"minutes.":[74],"The":[75],"mean":[76],"value":[77],"was":[78],"21.0":[79],"6.4":[81],"for":[88],"120":[89],"tissue/serum":[93],"ratio":[94],"0.91.":[96],"level":[99],"glandular":[101],"dominant":[102],"slightly":[104],"those":[107],"myoglandular":[109],"(P":[111],"less":[112],"0.1).":[114],"Judging":[115],"from":[116],"its":[117],"favorable":[118],"transfer":[119],"into":[120],"MIC":[125],"against":[126],"clinically":[127,139],"isolated":[128],"E.":[129],"coli,":[130],"Proteus":[131],"sp.":[132],"Klebsiella,":[134],"CZX":[135],"seemed":[136],"useful":[140],"treatment":[143],"infection.":[146]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}